Similar articles for PMID: 23243213

Year	Number of Results
1962	1
2003	1
2004	1
2007	5
2008	2
2009	4
2010	7
2011	10
2012	26
2013	24
2014	20
2015	17
2016	9
2017	17
2018	20
2019	11
2020	8
2021	0

1

Mineral metabolites and CKD progression in African Americans.

Scialla JJ, Astor BC, Isakova T, Xie H, Appel LJ, Wolf M. Scialla JJ, et al. J Am Soc Nephrol. 2013 Jan;24(1):125-35. doi: 10.1681/ASN.2012070713. Epub 2012 Dec 14. J Am Soc Nephrol. 2013. PMID: 23243213 Free PMC article.

2

Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.

Portale AA, Wolf MS, Messinger S, Perwad F, Jüppner H, Warady BA, Furth SL, Salusky IB. Portale AA, et al. Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1989-1998. doi: 10.2215/CJN.02110216. Epub 2016 Aug 25. Clin J Am Soc Nephrol. 2016. PMID: 27561289 Free PMC article.

3

Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.

Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL. Pavik I, et al. Nephrol Dial Transplant. 2013 Feb;28(2):352-9. doi: 10.1093/ndt/gfs460. Epub 2012 Nov 4. Nephrol Dial Transplant. 2013. PMID: 23129826 Free article.

4

Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Isakova T, Cai X, Lee J, Mehta R, Zhang X, Yang W, Nessel L, Anderson AH, Lo J, Porter A, Nunes JW, Negrea L, Hamm L, Horwitz E, Chen J, Scialla JJ, de Boer IH, Leonard MB, Feldman HI, Wolf M; CRIC Study Investigators. Isakova T, et al. Am J Kidney Dis. 2020 Feb;75(2):235-244. doi: 10.1053/j.ajkd.2019.07.022. Epub 2019 Oct 23. Am J Kidney Dis. 2020. PMID: 31668375

5

Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.

Shardlow A, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW. Shardlow A, et al. BMJ Open. 2017 Aug 23;7(8):e016528. doi: 10.1136/bmjopen-2017-016528. BMJ Open. 2017. PMID: 28838895 Free PMC article.

6

Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.

Nakano C, Hamano T, Fujii N, Matsui I, Tomida K, Mikami S, Inoue K, Obi Y, Okada N, Tsubakihara Y, Isaka Y, Rakugi H. Nakano C, et al. Clin J Am Soc Nephrol. 2012 May;7(5):810-9. doi: 10.2215/CJN.08680811. Epub 2012 Feb 23. Clin J Am Soc Nephrol. 2012. PMID: 22362065 Free article. Clinical Trial.

7

Disordered FGF23 and mineral metabolism in children with CKD.

Portale AA, Wolf M, Jüppner H, Messinger S, Kumar J, Wesseling-Perry K, Schwartz GJ, Furth SL, Warady BA, Salusky IB. Portale AA, et al. Clin J Am Soc Nephrol. 2014 Feb;9(2):344-53. doi: 10.2215/CJN.05840513. Epub 2013 Dec 5. Clin J Am Soc Nephrol. 2014. PMID: 24311704 Free PMC article.

8

Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.

Scialla JJ, Parekh RS, Eustace JA, Astor BC, Plantinga L, Jaar BG, Shafi T, Coresh J, Powe NR, Melamed ML. Scialla JJ, et al. Am J Nephrol. 2015;42(1):25-34. doi: 10.1159/000438999. Epub 2015 Aug 20. Am J Nephrol. 2015. PMID: 26287973 Free PMC article.

9

The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.

Taal MW, Thurston V, McIntyre NJ, Fluck RJ, McIntyre CW. Taal MW, et al. Kidney Int. 2014 Aug;86(2):407-13. doi: 10.1038/ki.2013.537. Epub 2014 Jan 15. Kidney Int. 2014. PMID: 24429404 Free article.

10

Parathyroid Hormone, Fibroblast Growth Factor 23, and Parameters of Phosphate Reabsorption.

Phelps KR, Mason DL. Phelps KR, et al. Am J Nephrol. 2018;47(5):343-351. doi: 10.1159/000489270. Epub 2018 May 18. Am J Nephrol. 2018. PMID: 29779023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed